Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Fernandez

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Radiation Oncology (London, England)|December 24, 2014
Use of FDG-PET to guide dose prescription heterogeneity in stereotactic body radiation therapy for lung cancers with volumetric modulated arc therapy: a feasibility studyBénédicte Henriques de Figueiredo, Mikael Antoine, Renaud Trouette, et al.
Clinical Nuclear Medicine|June 28, 2019
68Ga-PSMA-617 Compared With 68Ga-RM2 and 18F-FCholine PET/CT for the Initial Staging of High-Risk Prostate CancerRomain Schollhammer, Henri de Clermont Gallerande, Grégoire Robert, et al.
International Journal of Molecular Sciences|April 10, 2019
Neurotensin Receptor-1 Expression in Human Prostate Cancer: A Pilot Study on Primary Tumors and Lymph Node MetastasesClément Morgat, Adrien Chastel, Vincent Molinie, et al.
Molecular Imaging|June 14, 2013
Improvement of in vivo quantification of [123I]-Iodobenzovesamicol in single-photon emission computed tomography/computed tomography using anatomic image to brain atlas nonrigid registrationFrederic Lamare, Joachim Mazere, Mathieu Attila, et al.
IEEE Transactions on Medical Imaging|May 23, 2012
Image change detection using paradoxical theory for patient follow-up quantitation and therapy assessmentSimon David, Dimitris Visvikis, Gwénolé Quellec, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 11, 2017
Expression of Gastrin-Releasing Peptide Receptor in Breast Cancer and Its Association with Pathologic, Biologic, and Clinical Parameters: A Study of 1,432 Primary TumorsClément Morgat, Gaétan MacGrogan, Véronique Brouste, et al.
Head & Neck|August 29, 2015
Accuracy of (18) FDG PET-CT for treatment evaluation 3 months after completion of chemoradiotherapy for head and neck squamous cell carcinoma: 2-year minimum follow-upThomas Sagardoy, Philippe Fernandez, Abdullah Ghafouri, et al.
Plos One|January 16, 2019
Comparison of the binding of the gastrin-releasing peptide receptor (GRP-R) antagonist 68Ga-RM2 and 18F-FDG in breast cancer samplesClément Morgat, Romain Schollhammer, Gaétan Macgrogan, et al.
The Prostate|November 14, 2014
Comparative effectiveness of [(18) F]-fluorocholine PET-CT and pelvic MRI with diffusion-weighted imaging for staging in patients with high-risk prostate cancerJean-Baptiste Pinaquy, Henri De Clermont-Galleran, Gilles Pasticier, et al.
Plos One|November 4, 2025
Correction: Expansion of forest cover and coeval shifts in Later Stone Age land-use at Taforalt and Rhafas Caves, Morocco, as inferred from carbon isotopes in ungulate tooth enamelKayla B Worthey, Philippe Fernandez, Elaine Turner, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Radiation Oncology (London, England)|December 24, 2014
Use of FDG-PET to guide dose prescription heterogeneity in stereotactic body radiation therapy for lung cancers with volumetric modulated arc therapy: a feasibility studyBénédicte Henriques de Figueiredo, Mikael Antoine, Renaud Trouette, et al.
Clinical Nuclear Medicine|June 28, 2019
68Ga-PSMA-617 Compared With 68Ga-RM2 and 18F-FCholine PET/CT for the Initial Staging of High-Risk Prostate CancerRomain Schollhammer, Henri de Clermont Gallerande, Grégoire Robert, et al.
International Journal of Molecular Sciences|April 10, 2019
Neurotensin Receptor-1 Expression in Human Prostate Cancer: A Pilot Study on Primary Tumors and Lymph Node MetastasesClément Morgat, Adrien Chastel, Vincent Molinie, et al.
Molecular Imaging|June 14, 2013
Improvement of in vivo quantification of [123I]-Iodobenzovesamicol in single-photon emission computed tomography/computed tomography using anatomic image to brain atlas nonrigid registrationFrederic Lamare, Joachim Mazere, Mathieu Attila, et al.
IEEE Transactions on Medical Imaging|May 23, 2012
Image change detection using paradoxical theory for patient follow-up quantitation and therapy assessmentSimon David, Dimitris Visvikis, Gwénolé Quellec, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 11, 2017
Expression of Gastrin-Releasing Peptide Receptor in Breast Cancer and Its Association with Pathologic, Biologic, and Clinical Parameters: A Study of 1,432 Primary TumorsClément Morgat, Gaétan MacGrogan, Véronique Brouste, et al.
Head & Neck|August 29, 2015
Accuracy of (18) FDG PET-CT for treatment evaluation 3 months after completion of chemoradiotherapy for head and neck squamous cell carcinoma: 2-year minimum follow-upThomas Sagardoy, Philippe Fernandez, Abdullah Ghafouri, et al.
Plos One|January 16, 2019
Comparison of the binding of the gastrin-releasing peptide receptor (GRP-R) antagonist 68Ga-RM2 and 18F-FDG in breast cancer samplesClément Morgat, Romain Schollhammer, Gaétan Macgrogan, et al.
The Prostate|November 14, 2014
Comparative effectiveness of [(18) F]-fluorocholine PET-CT and pelvic MRI with diffusion-weighted imaging for staging in patients with high-risk prostate cancerJean-Baptiste Pinaquy, Henri De Clermont-Galleran, Gilles Pasticier, et al.
Plos One|November 4, 2025
Correction: Expansion of forest cover and coeval shifts in Later Stone Age land-use at Taforalt and Rhafas Caves, Morocco, as inferred from carbon isotopes in ungulate tooth enamelKayla B Worthey, Philippe Fernandez, Elaine Turner, et al.
Pageof 8